TRPV1 receptor is an important analgesia target. Its antagonists are expected to prevent pain perception by blocking the receptor directly. In this letter, eight dihydroisoquinoline-2(1H)-carbothioamide derivatives were designed and synthesized as TRPV1 antagonists. The benzene ring was modified with different substitutional groups. Preliminary biological tests suggested that the new compounds exhibited TRPV1 antagonist activity and different analgesia effects, some of which were promising as analgesia drugs.
TRPV1受体是一个重要的镇痛靶点,其
拮抗剂有望通过直接阻断受体来预防疼痛感知。在本文中,我们设计并合成了8种二
氢异喹啉-2(1H)-
硫代
酰胺衍
生物作为TRPV1
拮抗剂,并对
苯环进行了不同的取代基修饰。初步的
生物测试表明,这些新化合物显示出TRPV1拮抗活性,并具有不同的镇痛效果,其中一些有望成为
镇痛药物。